Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NL vs KRO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KRO Captures Overall Composite Edge (48.7 HOLD vs 46.5 HOLD), While NL Leads 3–2 on Growth & Valuation Pillars

KRO Overall Winner 6-Pillar Tally: NL 3 – 2 KRO (1 Tie) Matrix Metrics: NL 3 – 7 KRO

As of Nov 16, 2026, Kronos Worldwide, Inc. (KRO) captures the overall head-to-head institutional edge over NL Industries, Inc. (NL) on higher Unified Composite conviction (48.7/100 HOLD vs. 46.5/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Growth & Scale), while NL wins 3–2 across the 6-pillar growth and valuation breakdown. NL trades at $7.11 (26.2x Forward P/E, 18.6% operating margin) versus KRO at $7.95 (12.9x Forward P/E, 2.4% operating margin).

  • Growth vs. Quality Trade-Off: KRO earns the overall head-to-head edge with a stronger Unified Composite Score (48.7/100 HOLD vs. NL 46.5/100 HOLD) and 1.18β · 56% Vol risk profile, whereas NL leads top-line expansion (+10.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NL vs KRO
NL NYSE
NL Industries, Inc.
Industrial Inorganic Chemicals
$7.11
+0.57% 1D
Market Cap $332.5M
TTM Revenue $166M
Forward P/E 26.2x
Beta / 30D Vol 0.33β · 41% Vol
Unified Composite Score
46.5 / 100 HOLD
Tech 29.0 Fund 43.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 53
RSI-14: 52.8 · SMA20: $6.99 · SMA50: $6.94
KRO NYSE Head-to-Head Winner
Kronos Worldwide, Inc.
Industrial Inorganic Chemicals
$7.95
-4.1% 1D
Market Cap $954.2M
TTM Revenue $2.03B
Forward P/E 12.9x
Beta / 30D Vol 1.18β · 56% Vol
Unified Composite Score
48.7 / 100 HOLD
Tech 44.0 Fund 47.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.8 · SMA20: $7.77 · SMA50: $7.86

6-Pillar Scorecard Institutional Category Breakdown (NL 3 – 2 KRO)

Columns: Metric · NL · KRO
1. Valuation Multiples KRO
Forward P/E 26.2x 12.9x
Trailing P/E 26.2x 4.9x
PEG Ratio N/M 1.36x
EV / Revenue 2.0x 0.5x
2. Growth & Scale KRO
Revenue Growth (YoY) +10.1% +18.4%
Earnings Growth (YoY) N/A +124.8%
TTM Revenue (USD) $166M $2.03B
Market Cap $332.5M $954.2M
3. Profitability & Quality NL
Gross Margin 32.5% 15.5%
Operating Margin 18.6% 2.4%
Net Profit Margin -3.0% -1.9%
Return on Equity (ROE) -0.5% -4.7%
4. Balance Sheet & Cash Flow NL
Cash Generation (TTM) $34M EBITDA $111M EBITDA
Cash Flow Margin 20.7% EBITDA Mgn 5.5% EBITDA Mgn
Net Cash / Leverage $7.61 Book/Sh · -0.5% ROE $6.81 Book/Sh · -4.7% ROE
Dividend Yield 5.37% 2.38%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 43.1% (25th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat NL
OpEx & R&D Intensity 13.9% of Rev ($23M) 13.1% of Rev ($266M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Security & Protection Services Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NL (3) vs KRO (7)
Institutional Metric NL KRO Criterion Row Edge
Market Capitalization
Scale
$332.5M $954.2M Larger Scale KRO
Trailing P/E Ratio
Valuation
26.2x 4.9x Lower Multiple KRO
Forward P/E Ratio
Valuation
26.2x 12.9x Lower Multiple KRO
Revenue Growth (YoY)
Growth
+10.1% +18.4% Higher Growth KRO
Operating Margin (TTM)
Profitability
18.6% 2.4% Higher Margin NL
Net Profit Margin
Profitability
-3.0% -1.9% Higher Margin KRO
Return on Equity (ROE)
Capital Efficiency
-0.5% -4.7% Higher ROE NL
52-Week Range Position
Momentum
58% ($5–$9) 75% ($4–$9) Stronger Trend KRO
Beta / 30D Volatility
Risk Regime
0.33β · 41% Vol 1.18β · 56% Vol Lower Realized Risk NL
Unified Institutional Score
Composite Signal
46.5 / 100 (HOLD) 48.7 / 100 (HOLD) Higher Composite KRO
Trailing 12M Revenue (USD)
Operating Scale
$166M $2.03B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
32.5% 15.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.0x EV/Rev 1.36x PEG · 0.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$34M EBITDA ($7.61 Book/Sh · -0.5% ROE) $111M EBITDA ($6.81 Book/Sh · -4.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NL +0.24 pp
NL: +7.24% · KRO: +7.0%
3M Horizon NL +9.13 pp
NL: +9.38% · KRO: +0.25%
6M Horizon KRO +15.55 pp
NL: +0.0% · KRO: +15.55%
1Y Horizon KRO +36.6 pp
NL: +28.34% · KRO: +64.94%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NL vs KRO. Trailing 12-month operating profitability (NL 18.6% vs KRO 2.4%) and valuation multiples (NL 26.2x vs KRO 12.9x Forward P/E) are benchmarked directly in Pillar 4 below.

NL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$166M
Gross Margin32.5%
Op. Margin18.6%
ROE / Fwd P/E-0.5% · 26.2x
KRO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.03B
Gross Margin15.5%
Op. Margin2.4%
ROE / Fwd P/E-4.7% · 12.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
KRO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 43.1%
IV Percentile 25th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KRO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NL Moat Profile Scale & Operating Efficiency Moat
Security & Protection Services Operator
Competes within the Security & Protection Services value chain with $332.5M market capitalization and 18.6% operating margin.
OpEx & R&D Reinvestment 13.9% of Rev ($23M)
90D Engineering Disclosures 0 Published
KRO Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $954.2M market capitalization and 2.4% operating margin.
OpEx & R&D Reinvestment 13.1% of Rev ($266M)
90D Engineering Disclosures 0 Published

Investor FAQ NL vs KRO Key Questions & Quantitative Answers

As of Nov 16, 2026, Kronos Worldwide, Inc. (KRO) captures the overall head-to-head institutional edge over NL Industries, Inc. (NL) on higher Unified Composite conviction (48.7/100 HOLD vs. 46.5/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Growth & Scale), while NL wins 3–2 across the 6-pillar growth and valuation breakdown. NL trades at $7.11 (26.2x Forward P/E, 18.6% operating margin) versus KRO at $7.95 (12.9x Forward P/E, 2.4% operating margin). Growth vs. Quality Trade-Off: KRO earns the overall head-to-head edge with a stronger Unified Composite Score (48.7/100 HOLD vs. NL 46.5/100 HOLD) and 1.18β · 56% Vol risk profile, whereas NL leads top-line expansion (+10.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

KRO leads the Growth & Scale pillar: NL posts +10.1% YoY revenue growth and N/A YoY earnings growth on $166M TTM revenue (32.5% gross margin, 18.6% operating margin), compared with KRO at +18.4% YoY revenue growth and +124.8% YoY earnings growth on $2.03B TTM revenue (15.5% gross margin, 2.4% operating margin). On trailing 12-month operating scale, NL generates $166M in USD-normalized revenue versus $2.03B for KRO. In operating R&D and SG&A reinvestment, NL deploys 13.9% of Rev ($23M) (0 90-day corporate R&D disclosures) versus 13.1% of Rev ($266M) (0 disclosures) for KRO.

KRO screens cheaper on headline valuation multiples. NL trades at 26.2x Forward P/E, 26.2x Trailing P/E, N/M PEG, and 2.0x EV/Revenue (20.7% EBITDA margin), whereas KRO trades at 12.9x Forward P/E, 4.9x Trailing P/E, 1.36x PEG, and 0.5x EV/Revenue (5.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NL (-0.5% ROE) versus KRO (-4.7% ROE) capital efficiency.

In options market volatility and institutional positioning, NL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.33β · 41% Vol realized risk). By comparison, KRO carries 43.1% implied volatility (25th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.18β · 56% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.